COVID-19 RNA-based variant-adapted vaccine candidate(s)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for COVID-19 RNA-based variant-adapted vaccine candidate(s), covering 2025-12-22 to 2025-12-22. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Learn About COVID-19 RNA-Based Variant-Adapted Vaccine Candidate(s) Against SARS-CoV-2 in Participants Ages 12 Through 64 Years Considered at Higher Risk of Severe COVID-19, and Participants Ages ≥65 Years [Phase 3]